Larry Robbins's TEVA Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 16.69 M shares of Teva Pharmaceutical Industries Limited (TEVA) worth $337.19 M, representing 7.51% of the portfolio. First purchased in 2015-Q2, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Larry Robbins has maintained a strategic position in TEVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 6.32 M shares. Largest reduction occurred in Q2 2016, reducing 2.5 M shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2015 | +2.84 M | New Buy | 2.84 M | $59.10 |
| Q3 2015 | +1.34 M | Add 47.26% | 4.19 M | $56.46 |
| Q4 2015 | +1.77 M | Add 42.18% | 5.96 M | $65.64 |
| Q1 2016 | -376,484 | Reduce 6.32% | 5.58 M | $53.51 |
| Q2 2016 | -2.5 M | Reduce 44.75% | 3.08 M | $50.23 |
| Q3 2016 | -906,703 | Reduce 29.41% | 2.18 M | $46.01 |
| Q4 2016 | -2.18 M | Sold Out | 0 | $0.00 |
| Q4 2023 | +1.6 M | New Buy | 1.6 M | $10.44 |
| Q1 2024 | +5.9 M | Add 367.48% | 7.5 M | $14.11 |
| Q2 2024 | +1.66 M | Add 22.08% | 9.16 M | $16.25 |
| Q3 2024 | -701,317 | Reduce 7.66% | 8.46 M | $18.02 |
| Q1 2025 | +6.32 M | Add 74.76% | 14.78 M | $15.37 |
| Q2 2025 | +1.05 M | Add 7.07% | 15.82 M | $16.76 |
| Q3 2025 | +868,457 | Add 5.49% | 16.69 M | $20.20 |
Larry Robbins's Teva Pharmaceutical Industries Limited Investment FAQs
Larry Robbins first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q2 2015, acquiring 2,844,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Teva Pharmaceutical Industries Limited (TEVA) for 15 quarters since Q2 2015.
Larry Robbins's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q1 2025, adding 14,778,641 shares worth $227.15 M.
According to the latest 13F filing for Q3 2025, Larry Robbins's firm, Glenview Capital Management, LLC, owns 16,692,680 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $337.19 M.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 7.51% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 16,692,680 shares, as reported at the end of Q3 2025.